|
|
|
|
|
16.01.26 - 04:24
|
Akeso Confident of Cancer Drug′s FDA Approval Odds (Bloomberg)
|
|
|
Chinese biopharmaceutical firm Akeso's CFO, Bing Wang, says he feels “pretty good” about the chances of receiving approval from US regulators for ivonescimab, the company's key cancer drug developed in partnership with US-based Summit Therapeutics. Wang speaks exclusively on Bloomberg: The China Show from San Francisco, where the marquee industry event hosted by JPMorgan is taking place. (Source: Bloomberg)...
|
|
|
16.01.26 - 01:51
|
JPMorganChase Declares Preferred Stock Dividends (Business Wire)
|
|
|
NEW YORK--(BUSINESS WIRE)--JPMorgan Chase & Co. (NYSE: JPM) (“JPMorganChase” or the “Firm”) has declared dividends on the outstanding shares of the Firm's Series DD, EE, GG, JJ, KK, LL, MM and NN preferred stock. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news.
JPMorgan Chase & Co. (NYSE: JPM) is a leading financial services firm based in the United States of America (“U.S.”), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $362 billion in stockholders' equity as of December 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the J.P. Morgan and Chase brands, the Firm serves millions of customers in the U.S., and many of the world's most prominent corporate, institutional and government clients globally. Information about JPMorgan Chase & Co. is available at www.jpmorganc...
|
|
|
15.01.26 - 23:54
|
Dimon Says Lot of Good ′Short Term Things′ In US Economy (Bloomberg)
|
|
|
JPMorgan CEO Jamie Dimon told Bloomberg's David Rubenstein that he sees a lot of good 'short term things' in the US economy, including Trump's 'big beautiful bill' and deregulation coming out of the White House. Dimon also called on industry leaders to put the good of the US above their own companies or profits, saying that there is too much focused on self-interest and people should 'open our eyes' and do the right things. (Source: Bloomberg)...
|
|
|
|
|
15.01.26 - 23:42
|
Dimon Says ′No Chance′ He′d Take Fed Chair Position (Bloomberg)
|
|
|
JPMorgan CEO Jamie Dimon told Bloomberg's David Rubenstein that there was 'no chance' he would take up the role of chair of the Federal Reserve, but would consider taking on the Treasury if the president asked him to serve as secretary. However, he joked that he might like being his own boss too much to take the role. Dimon also weighed in on questions around the Fed's role, saying that chipping away at Fed independence drives rates higher. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
15.01.26 - 22:48
|
JPMorgan′s Dimon on Being Fed Chair: ′Absolutely No Chance′ (Bloomberg)
|
|
|
JPMorgan Chase Chair and CEO Jamie Dimon says there's no chance he'll be Federal Reserve chair but doesn't rule out becoming US Treasury Secretary during an interview with David Rubenstein at the US Chamber of Commerce's 2026 State of American Business. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.01.26 - 15:31
|
Abschied von Apple Card hebt Gewinn von Goldman Sachs - Aktie verliert (Cash)
|
|
|
- Die Abgabe des Geschäfts mit Apple-Kreditkarten an JPMorgan Case hat der US-Investmentbank Goldman Sachs Ende 2025 einen milliardenschweren Gewinnsprung eingebracht. Das Geldhaus löste im vierten Quartal insgesamt Rückstellungen von fast 2,1 Milliarden US-Dollar (1,8 Mrd Euro) für mögliche Kreditausfälle auf, wie es am Donnerstag in New York mitteilte. Einen Rekord stellten Goldmans Händler derweil im Aktienhandel auf....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
